滬深市場個股詳情

002382 藍帆醫療

添加自選

5.67
+0.12+2.16%

休市中 04/30 15:00 (北京)

57.10億總市值-9675市盈率TTM

藍帆醫療股票討論區

登錄發表評論

Moomoo AI

03/15 07:20

The company's long-term performance remains disappointing despite recent share price rise. Falling revenue is a concern and weak share price performance reflects this. Dividend payments have significantly contributed to shareholder returns.

Blue Sail MedicalLtd (SZSE:002382) Shareholders Are up 7.2% This Past Week, but Still in the Red Over the Last Three Years

Moomoo AI

02/03 06:38

Investors may believe the company will underperform the industry, causing a low P/S ratio. The declining revenue and predicted industry growth could further lower the ratio. If recent revenue trends persist, the share price may remain stable.

Lacklustre Performance Is Driving Blue Sail Medical Co.,Ltd.'s (SZSE:002382) 25% Price Drop

Moomoo AI

01/19 14:40

The company's falling revenue and EBIT loss are concerning. The balance sheet appears strained due to the company's debt and liabilities, making the stock very risky. The company's ability to manage its debt without dilution needs to be closely examined.

Is Blue Sail MedicalLtd (SZSE:002382) A Risky Investment?

Moomoo AI

2023/10/23 11:40

Blue Sail Medical's revenue drop and stock price slump imply market expectations for growth, especially from non-profit firms. To meet these hopes, revenue growth is key. Broad market uncertainty may affect share prices, indicating a potential need to monitor fundamentals for opportunities. Last year's underperformance could hint at ongoing hurdles.

Shareholders in Blue Sail MedicalLtd (SZSE:002382) Have Lost 70%, as Stock Drops 5.4% This Past Week

Zeff The Great

2023/10/06 17:15

The business landscape has changed

$TOPGLOV(7113.MY)$ has just released it’s latest quarterly report , the revenue continue to drop due to lower volume of sales and selling prices. It is also noteworthy that there were impairments made on assets and goodwill due to the rationalisation exercise for the company’s operation, amounting to RM 389 mil .
Nevertheless, the “actual” performance actually improved to a loss of RM 65 mil , due to better cost structure and cost management .
While the local ...

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

滬深

綜合熱度